Edinburgh Bioquarter

Sep 6, 2024 | academic.oup.com | Edinburgh Bioquarter |Wei Hao

Functional neurological disorder (FND) is now recognized as a common, valid and treatable disorder,2 with population studies suggesting a prevalence of 50–100 cases in 100 000.2 FND typically affects women, with a female preponderance of 60%–80% across studies, although the gender gap narrows with increasing age.3 It remains, however a neglected condition, influenced by outdated misperceptions and attitudes, and inadequate knowledge and training.4-6 Although newer developments aim to address...

Sep 6, 2024 | academic.oup.com | Edinburgh Bioquarter |Wei Hao

Functional neurological disorder (FND) is now recognized as a common, valid and treatable disorder,2 with population studies suggesting a prevalence of 50–100 cases in 100 000.2 FND typically affects women, with a female preponderance of 60%–80% across studies, although the gender gap narrows with increasing age.3 It remains, however a neglected condition, influenced by outdated misperceptions and attitudes, and inadequate knowledge and training.4-6 Although newer developments aim to address...

Jun 6, 2024 | link.springer.com | Edinburgh Bioquarter

AbstractFactors increasing the risk of maternal critical illness are rising in prevalence in maternity populations. Studies of general critical care populations highlight that severe illness is associated with longer-term physical and psychological morbidity. We aimed to compare short- and longer-term outcomes between women who required critical care admission during pregnancy/puerperium and those who did not.

Sep 7, 2023 | journals.plos.org | Richard Taylor |Ross Dobie |Edinburgh Bioquarter |Rose Ruiz Daniels

Citation: Ruiz Daniels R, Taylor RS, Dobie R, Salisbury S, Furniss JJ, Clark E, et al. (2023) A versatile nuclei extraction protocol for single nucleus sequencing in non-model species–Optimization in various Atlantic salmon tissues. PLoS ONE 18(9): e0285020.

Jun 9, 2023 | ukspa.org.uk | Edinburgh Bioquarter

Jun 9, 2023 | Edinburgh BioQuarter, Member News New laboratory space and expert teams will help accelerate the development of potentially life-saving cell therapies The facility enhances Edinburgh’s role as a hub for cell therapies; with the aim to attract further international companies to the area The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, has today officially opened its...